| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |